PLIANT THERAPEUTICS, INC. Contracts & Agreements

28 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Loan and Security Agreement, by and among the Registrant, the lenders from time to time party thereto and Oxford Finance LLC, dated March 11, 2024
Loan Agreements
PLIANT THERAPEUTICS, INC.
2024
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
PLIANT THERAPEUTICS, INC.
2024
Lease Agreement by and between HCP BTC, LLC and the Company, dated September 28, 2023
Lease Agreements
PLIANT THERAPEUTICS, INC.
2023
Termination Agreement by and between Healthpeak OP, LLC and the Company, dated September 28, 2023
Termination Agreements
PLIANT THERAPEUTICS, INC.
2023
Underwriting Agreement, dated as of January 24, 2023, by and among Pliant Therapeutics, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the...
Underwriting Agreements
PLIANT THERAPEUTICS, INC.
2023
Underwriting Agreement, dated as of July 12, 2022, by and among Pliant Therapeutics, Inc. and J.P. Morgan Securities LLC and Cowen and Company, LLC, as representatives of the...
Underwriting Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2022
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
PLIANT THERAPEUTICS, INC.
2022
Description of the Registrants Securities
PLIANT THERAPEUTICS, INC.
2021
Offer Letter, by and between the Registrant and Mike Ouimette, dated August 17, 2020
PLIANT THERAPEUTICS, INC.
2020
Form of Underwriting Agreement
Underwriting Agreements
PLIANT THERAPEUTICS, INC.
2020
Specimen Common Stock Certificate of the Registrant
Stock Agreements
PLIANT THERAPEUTICS, INC.
2020
2020 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020
2020 Employee Stock Purchase Plan
Stock Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020
Non-Employee Director Compensation Policy
Compensation Agreements
PLIANT THERAPEUTICS, INC.
2020
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019
Investor Rights Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020
2015 Equity Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
DE
2020
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
PLIANT THERAPEUTICS, INC.
2020
Prior Non-Employee Director Compensation Policy
Compensation Agreements
PLIANT THERAPEUTICS, INC.
2020
Non-Employee Director Compensation Policy
Compensation Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
2020
Executive Severance Plan
Severance Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
DE
2020
Offer Letter, by and between the Registrant and Bernard Coulie, M.D., Ph.D., dated October 12, 2015
PLIANT THERAPEUTICS, INC.
2020
Offer Letter, by and between the Registrant and Hans Hull, J.D., dated February 10, 2016
PLIANT THERAPEUTICS, INC.
2020
Offer Letter, by and between the Registrant and Keith Cummings, M.D., MBA, dated November 29, 2018
PLIANT THERAPEUTICS, INC.
2020
Offer Letter, by and between the Registrant and ric Lefebvre, M.D., dated February 28, 2018
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
2020
Offer Letter, by and between the Registrant and Barbara Howes, dated May 1, 2019
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
2020
Form of Indemnification Agreement, by and between the Registrant and each of its directors and certain officers
Indemnification Agreements
PLIANT THERAPEUTICS, INC.
2020
Office Lease, by and between the Registrant and 260 Littlefield Avenue South San Francisco, California 94080, dated February 6, 2018
Lease Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020
Collaboration and License Agreement, by and between the Registrant and Novartis Institutes For Biomedical Research, Inc., dated October 17, 2019
Collaboration Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020